Human Services
(P112)
IRS Verified
DX Registered
990 on File
MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION
Financial strength (30%)
80/100
Reliability (20%)
55/100
Effectiveness (25%)
85/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Our MissionTo advance the scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer by:Increasing funding and support of research into the biological mechanisms and clinical strategies related to the prevention, diagnosis, and treatment of pancreatic cancer;Facilitating and enhancing the dialogue among members of the medical and scientific communities about basic and clinical research efforts that relate to pancreatic cancer;Heightening public awareness of pancreatic cancer diagnosis, treatment, and prevention and providing informational support for pancreatic cancer patients, their families, and friends.
Financial Overview — FY 2025
$37.2M
Total Revenue
$27.2M
Total Expenses
$79.0M
Net Assets
26
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
80.3%
Fundraising Efficiency
5139.3%
Operating Reserve
34.89x
Liability-to-Asset
13.7%
Revenue Diversification
93.2%
Executive Compensation
$1.3M
Compared with Peers
FY 2025
Compared with 1,399 similar organizations
(United States, Human Services, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
80.3% | 87.1% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.5% | 11.4% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
11.2% | 0.3% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
5139.3% | 459.1% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
34.9 mo | 7.3 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
13.7% | 28.4% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
93.2% | 91.8% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
63.5% | 6.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-12.2% | 5.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
26.9% | 2.5% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $37.2M | $27.2M | $79.0M | 80.3% | 26 |
| 2024 | $22.7M | $31.0M | $64.9M | 82.8% | 28 |
| 2023 | $18.3M | $28.7M | $69.3M | 80.3% | 30 |
| 2022 | $30.4M | $33.8M | $70.0M | 82.9% | 25 |
| 2021 | $24.5M | $21.7M | N/A | — | 25 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.